China vs United States of America: Leprosy registered prevalence rate per 1 000 000 population
China
0.404
in 2024
United States of America
0.424
in 2023
China rank
101st
United States of America rank
100th
Leprosy registered prevalence rate per 1 000 000 population over time
- China
- United States of America
How they compare
United States of America currently reports 0.424 against 0.404 in China, a difference of 0.02.
The two have swapped places 1 time across 9 shared years of data; in 2012 it was China ahead.
China ranks 101st and United States of America ranks 100th of 169 countries.
Across the 2 decades both report, China averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | China | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9417 | 0.8172 | 0.1245 | China |
| 2020s | 0.4565 | 0.647 | 0.1905 | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher leprosy registered prevalence rate per 1 000 000 population, China or United States of America?
- United States of America, at 0.424 against 0.404 in China as of 2023.
- What is the difference in leprosy registered prevalence rate per 1 000 000 population between China and United States of America?
- 0.02, with United States of America ahead.
- How many years of comparable data are there for China and United States of America?
- 9 years are reported by both, from 2012 to 2023.
- How do China and United States of America rank globally for leprosy registered prevalence rate per 1 000 000 population?
- China ranks 101st and United States of America ranks 100th of 169 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Leprosy registered prevalence rate per 1 000 000 population. Statizoid refreshes it automatically from the source and publishes the full history for both places.